MENU
HRMY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Harmony Biosciences Holdings (HRMY) Earnings Date & Reports
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs... Show more
A.I. Advisor
published Earnings
HRMY is expected to report earnings to fall 23.80% to 97 cents per share on November 03
Q3'26
Est.
$0.98
Q2'26
Beat
by $0.40
Q1'26
Missed
by $0.21
Q4'25
Missed
by $0.29
Q3'25
Beat
by $0.34
The last earnings report on August 04 showed earnings per share of $1.28, beating the estimate of 87 cents. With 94.29K shares outstanding, the current market capitalization sits at 2.23B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders
Industry Biotechnology
Profile
Details
Industry
N/A
Address
630 W. Germantown Pike
Phone
+1 484 539-9800
Employees
293
Web
https://www.harmonybiosciences.com